Kennedy Capital Management LLC Has $15.27 Million Holdings in ICU Medical, Inc. $ICUI

Kennedy Capital Management LLC raised its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 991.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 127,297 shares of the medical instruments supplier’s stock after purchasing an additional 115,638 shares during the quarter. Kennedy Capital Management LLC’s holdings in ICU Medical were worth $15,271,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the stock. River Road Asset Management LLC increased its stake in ICU Medical by 207.0% during the second quarter. River Road Asset Management LLC now owns 651,492 shares of the medical instruments supplier’s stock valued at $83,658,000 after acquiring an additional 439,263 shares during the period. Norges Bank acquired a new position in shares of ICU Medical in the second quarter valued at $36,633,000. UBS Group AG raised its stake in shares of ICU Medical by 239.8% in the 3rd quarter. UBS Group AG now owns 386,555 shares of the medical instruments supplier’s stock valued at $46,371,000 after buying an additional 272,782 shares in the last quarter. Schroder Investment Management Group boosted its position in shares of ICU Medical by 25.2% during the 3rd quarter. Schroder Investment Management Group now owns 796,704 shares of the medical instruments supplier’s stock valued at $93,246,000 after acquiring an additional 160,380 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in ICU Medical by 16.9% in the third quarter. Dimensional Fund Advisors LP now owns 872,993 shares of the medical instruments supplier’s stock valued at $104,718,000 after acquiring an additional 126,072 shares during the period. Institutional investors own 96.10% of the company’s stock.

ICU Medical Stock Up 0.3%

Shares of NASDAQ ICUI traded up $0.41 during mid-day trading on Friday, reaching $129.19. 68,335 shares of the company’s stock were exchanged, compared to its average volume of 273,317. The company has a current ratio of 2.39, a quick ratio of 1.15 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $3.19 billion, a price-to-earnings ratio of 6,424.81, a PEG ratio of 1.93 and a beta of 0.79. The business has a fifty day simple moving average of $148.23 and a 200 day simple moving average of $138.00. ICU Medical, Inc. has a twelve month low of $107.00 and a twelve month high of $160.29.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, February 19th. The medical instruments supplier reported $1.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.68 by $0.23. ICU Medical had a return on equity of 7.33% and a net margin of 0.03%.The firm had revenue of $535.94 million during the quarter, compared to analysts’ expectations of $541.20 million. During the same quarter in the prior year, the company earned $2.11 EPS. The company’s revenue was down 14.1% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. As a group, equities analysts expect that ICU Medical, Inc. will post 4.11 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ICUI shares. Piper Sandler lifted their price objective on ICU Medical from $172.00 to $178.00 and gave the company an “overweight” rating in a report on Friday, February 20th. Wall Street Zen raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Sunday, February 15th. KeyCorp boosted their target price on ICU Medical from $175.00 to $180.00 and gave the stock an “overweight” rating in a report on Friday, February 20th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of ICU Medical in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $179.33.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.